CTOs on the Move

Volpara Health

www.volpara.com

 
Volpara Health provides an advanced AI software platform that enables a high-quality, optimized and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, the Volpara Breast Health Platform collects and analyzes information to better understand a patient`s breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. More than thirteen million women across 39 countries have had their breast density assessed by Volpara. The company`s software is installed in approximately 2000 leading facilities worldwide, including top cancer centers in the United States. Volpara Health`s technology has been the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.volpara.com
  • 19000 33rd Avenue W Suite 130
    Lynnwood, WA USA 98036
  • Phone: 800.305.3865

Executives

Name Title Contact Details

Similar Companies

WellGen

WellGen is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in N Brunswick, NJ. To find more information about WellGen, please visit www.amphioncap.com

White Healthcare Center Inc

Tealwood Care Centers, Inc. was formed in January 1989 as a long term care, for-profit company, dedicated to serving the needs of skilled nursing facility residents. Our goals go beyond taking care of the resident's needs in a safe and comfortable

Spire Health

Spire’s Remote Patient Monitoring service pairs revolutionary respiratory sensing technology with licensed medical staff to identify changes in patient health and intervene earlier.

Keller Medical Communications

Keller Medical Communications is a Newburyport, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.